A comparison between different anti-retroviral therapy regimes on soluble inflammation markers: a pilot study.
Martina MaritatiTrentini AlessandroNunzia ZanottaManola ComarTiziana BelliniLaura SighinolfiCarlo ContiniPublished in: AIDS research and therapy (2020)
Our results seem to discourage the administration of PI as a third drug in a virologically effective antiretroviral regimen, as its use is linked to the detection of higher levels of pro-inflammatory mediators in comparison with INI and NNRTI.